Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review. (August 2021)
- Record Type:
- Journal Article
- Title:
- Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review. (August 2021)
- Main Title:
- Gemcitabine-induced dilated-cardiomyopathy in patient with platinum-refractory ovarian-cancer: A case report and literature review
- Authors:
- Raimondi, Lucrezia
Raimondi, Filippo Maria
Rossi, Luigi
Lazzeroni, Rachele
Pietranera, Marta
Di Benedetto, Laura
Gozzi, Elisa
Spinelli, Gian Paolo - Abstract:
- Introduction: Gemcitabine is a nucleoside analog and pyrimidine antimetabolite that inhibits RNA synthesis, currently approved for use to treat a variety of cancers, among which ovarian cancers. Gemcitabine is considered relatively safe and it is generally well tolerated, with rarely reported cardiac side effects. Case report: We report a case of gemcitabine induced dilated cardiomyopathy in a 41-year-old woman receiving gemcitabine as second line treatment for platinum-resistant ovarian cancer without pre-existing hypertension or significant cardiac history. Management and Outcome: The patient presented with clinical symptoms and laboratory and imaging results suggestive of congestive cardiac failure, with a left ventricular ejection fraction of 15%. Gemcitabine administration was stopped and Furosemide with ACE-inhibitors and Beta-blocker agents were initiated. At that point the clinical situation improved: symptoms and findings disappeared with gemcitabine cessation. Discussion: Our case demonstrated for the first time objective evidence for dilated cardiomyopathy induced by gemcitabine in a young patient with platinum-resistant ovarian cancer without pre-existing significant cardiac history. Although rare, gemcitabine-induced cardiotoxicity should be promptly recognized in order to take appropriate measures to manage it.
- Is Part Of:
- Journal of oncology pharmacy practice. Volume 27:Number 6(2021)
- Journal:
- Journal of oncology pharmacy practice
- Issue:
- Volume 27:Number 6(2021)
- Issue Display:
- Volume 27, Issue 6 (2021)
- Year:
- 2021
- Volume:
- 27
- Issue:
- 6
- Issue Sort Value:
- 2021-0027-0006-0000
- Page Start:
- 1542
- Page End:
- 1547
- Publication Date:
- 2021-08
- Subjects:
- Gemcitabine -- dilated cardiomyopathy -- cardiotoxicity -- ovarian cancer -- platinum-resistant
Cancer -- Chemotherapy -- Periodicals
Clinical pharmacology -- Periodicals
616.994061 - Journal URLs:
- http://opp.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/1078155220982044 ↗
- Languages:
- English
- ISSNs:
- 1078-1552
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18243.xml